Product Information
ASTAGRAF XL 5 MG CAPSULE is a brand product labeled by Astellas Pharma US, Inc., priced at $27.7722 per EA under NDC 00469068773. Its NADAC has been published 74 times since Aug 21, 2024.
Strength
5 mg/1
Manufacturer
Astellas Pharma US, Inc.NDC
00469068773
Classification
Brand
Dosage Form
CAPSULE, COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
1/13/2025
Active Ingredients
TACROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA204096On Market Since
7/19/2013
Pharmacological Classes
Price Statistics
The NADAC for ASTAGRAF XL 5 MG CAPSULE has been published 74 times since Aug 21, 2024, and over the history we have for it it has risen 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $27.7722 per EA |
|---|---|
| All-time high | $27.7722 (Jan 14, 2026) |
| All-time low | $26.8105 (Aug 21, 2024) |
| 52-week high | $27.7722 |
| 52-week low | $27.7722 |
| Median price | $27.7722 |
| Average price | $27.5133 |
| Largest weekly change | +3.0% (Jan 22, 2025) |
| Weeks tracked | 74 |
| Tracking since | Aug 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tacrolimus extended-release capsules market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ASTAGRAF XL 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ASTAGRAF XL 5 MG CAPSULE, manufactured by Astellas Pharma US, Inc., is $27.7722 per EA (NDC 00469068773), effective Jan 14, 2026.
How has the price of ASTAGRAF XL 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ASTAGRAF XL 5 MG CAPSULE has risen 3.6%. It has been tracked across 74 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for ASTAGRAF XL 5 MG CAPSULE?
Since Aug 21, 2024, the NADAC for ASTAGRAF XL 5 MG CAPSULE has ranged from a low of $26.8105 (Aug 21, 2024) to a high of $27.7722 (Jan 14, 2026), with a median of $27.7722 per EA.
Are there cheaper alternatives to ASTAGRAF XL 5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ASTAGRAF XL 5 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures ASTAGRAF XL 5 MG CAPSULE?
ASTAGRAF XL 5 MG CAPSULE (NDC 00469068773) is labeled by Astellas Pharma US, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification